HIRO
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
HiRO acquires US CRO Courante Oncology, strengthens global footprint and operation capabilities 2023-09-01 10:00
Led by OrbiMed, HiRO Raised Tens of Millions of US Dollars in Series A Financing, to Offer Multinational Global Clinical Development Strategy 2022-03-18 08:00
1